Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khandan Keyomarsi

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|January 17, 2020
Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancerBenjamin B Mull, J Andrew Livingston, Nalini Patel, et al.
Cancer Research|September 9, 2018
Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted TherapiesJoseph A Caruso, Mylinh T Duong, Jason P W Carey, et al.
Carcinogenesis|June 1, 2013
Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent mannerMollianne McGahren Murray, Tuyen Bui, Michelle Smith, et al.
Cell Cycle (Georgetown, Tex.)|March 24, 2012
Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancerSaid Akli, Xin-Qiao Zhang, Jolanta Bondaruk, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cellsJoseph A Caruso, Rody Campana, Caimiao Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumorsSaid Akli, Tuyen Bui, Hannah Wingate, et al.
Cancer Research|October 3, 2008
Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma modelLaura A Lambert, Na Qiao, Kelly K Hunt, et al.
Cancer Research|August 3, 2007
Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathwaySaid Akli, Carolyn S Van Pelt, Tuyen Bui, et al.
Cancer Research|August 20, 2013
Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cellsMylinh T Duong, Said Akli, Sira Macalou, et al.
Cancer Research|March 2, 2016
Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer CellsKimberly S Lucenay, Iman Doostan, Cansu Karakas, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|January 17, 2020
Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancerBenjamin B Mull, J Andrew Livingston, Nalini Patel, et al.
Cancer Research|September 9, 2018
Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted TherapiesJoseph A Caruso, Mylinh T Duong, Jason P W Carey, et al.
Carcinogenesis|June 1, 2013
Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent mannerMollianne McGahren Murray, Tuyen Bui, Michelle Smith, et al.
Cell Cycle (Georgetown, Tex.)|March 24, 2012
Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancerSaid Akli, Xin-Qiao Zhang, Jolanta Bondaruk, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cellsJoseph A Caruso, Rody Campana, Caimiao Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumorsSaid Akli, Tuyen Bui, Hannah Wingate, et al.
Cancer Research|October 3, 2008
Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma modelLaura A Lambert, Na Qiao, Kelly K Hunt, et al.
Cancer Research|August 3, 2007
Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathwaySaid Akli, Carolyn S Van Pelt, Tuyen Bui, et al.
Cancer Research|August 20, 2013
Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cellsMylinh T Duong, Said Akli, Sira Macalou, et al.
Cancer Research|March 2, 2016
Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer CellsKimberly S Lucenay, Iman Doostan, Cansu Karakas, et al.
Pageof 11